Synthesis, radiolabeling and in vivo evaluation of [11C](R)-1-[4-[2-(4-methoxyphenyl)phenyl]piperazin-1-yl]-3-(2-pyrazinyloxy)-2-propanol, a potential PET radioligand for the 5-HT7 receptor

Hanne Demant Hansen, Enza Lacivita, Pantaleo Di Pilato, Matthias M Herth, Szabolcs Lehel, Anders Ettrup, Valdemar L Andersen, Agnete Dyssegaard, Paola De Giorgio, Roberto Perrone, Francesco Berardi, Nicola Antonio Colabufo, Mauro Niso, Gitte M Knudsen, Marcello Leopoldo

    16 Citations (Scopus)

    Abstract

    In the search for a novel serotonin 7 (5-HT7) receptor PET radioligand we synthesized and evaluated a new series of biphenylpiperazine derivatives in vitro. Among the studied compounds, (R)-1-[4-[2-(4-methoxyphenyl)phenyl]piperazin-1-yl]-3-(2-pyrazinyloxy)-2-propanol ((R)-16), showed the best combination of affinity, selectivity, and lipophilicity, and was thus chosen for carbon-11 labelling and evaluation in pigs. After intravenous injection, [(11)C](R)-16 entered the pig brain and displayed reversible tracer kinetics. Pretreatment with the 5-HT7 receptor selective antagonist SB-269970 (1) resulted in limited decrease in the binding of [(11)C](R)-16, suggesting that this radioligand is not optimal for imaging the brain 5-HT7 receptor in vivo but it may serve as a lead compound for the design of novel 5-HT7 receptor PET radioligands.

    Original languageEnglish
    JournalEuropean Journal of Medicinal Chemistry
    Volume79
    Pages (from-to)152-163
    Number of pages12
    ISSN0223-5234
    DOIs
    Publication statusPublished - 22 May 2014

    Keywords

    • Animals
    • Brain
    • CHO Cells
    • Carbon Isotopes
    • Cricetulus
    • HEK293 Cells
    • Humans
    • Kinetics
    • Ligands
    • Molecular Structure
    • Phenols
    • Piperazines
    • Positron-Emission Tomography
    • Propanols
    • Pyrazines
    • Radiopharmaceuticals
    • Receptors, Serotonin
    • Sulfonamides
    • Swine
    • Tissue Distribution

    Fingerprint

    Dive into the research topics of 'Synthesis, radiolabeling and in vivo evaluation of [11C](R)-1-[4-[2-(4-methoxyphenyl)phenyl]piperazin-1-yl]-3-(2-pyrazinyloxy)-2-propanol, a potential PET radioligand for the 5-HT7 receptor'. Together they form a unique fingerprint.

    Cite this